Results 61 to 70 of about 16,010,144 (294)
Reema Mody,1 Debra Eisenberg,2 Likun Hou,2 Siddhesh Kamat,2 Joseph Singer,2 Lauren B Gerson3 1Takeda Pharmaceuticals International Inc, Deerfield, IL, 2HealthCore Inc, Wilmington, DE, 3Stanford University School of Medicine, Stanford, CA, USA Background:
Mody R +5 more
doaj
Does the Integrated Management of Childhood Illness cost more than routine care? Results from the United Republic of Tanzania. [PDF]
OBJECTIVE\ud \ud The Integrated Management of Childhood Illness (IMCI) strategy is designed to address the five leading causes of childhood mortality, which together account for 70% of the 10 million deaths occurring among children worldwide annually ...
de Savigny, Don +5 more
core
Drugs previously repurposed to target blood cancers reduced neuroblastoma and glioblastoma cell growth and viability. However, their levels of anticancer activity were different and their clinical application may be problematic due to side effects at effective doses.
Abhishek Kharawatkar +4 more
wiley +1 more source
Junji Lin,1 Yunfeng Li,2 Haijun Tian,2 Michael J Goodman,1 Susan Gabriel,2 Tara Nazareth,2 Stuart J Turner,2,3 Stephen Arcona,2 Kristijan H Kahler21Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA; 2Health Economics and ...
Lin J +8 more
doaj
Background Studies show that hospital deaths bring significant health care costs, and the involvement of specialized palliative care can help to reduce these costs.
Anna-Maria Tolppanen +3 more
doaj +1 more source
Costs of health care associated infection
Key points:\ud * The costs of health care infections (HIAs) are difficult to measure and value.\ud * The costs are an important consideration for any decision to increase investment in infection control programs\ud * The greatest cost is bed days lost to
Halton, Kate A. +2 more
core
MagmaFlow: A desktop platform for artificial intelligence‐driven expression analysis
MagmaFlow is a free, no‐code platform for gene expression analysis. It generates interactive volcano plots, links genes to literature, pathways, and diseases, prioritizes candidates using millions of publications, identifies affected biological processes, builds network diagrams, and exports publication‐ready figures and reports for macOS and Windows ...
Carlos E. Buss +7 more
wiley +1 more source
Shih-Yin Chen,1 Ning Wu,1 Yuan-Chi Lee,1 Yang Zhao21Health Economics and Epidemiology, Evidera, Lexington, Massachusetts, 2Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USAPurpose: The aim of the ...
Chen SY, Wu N, Lee YC, Zhao Y
doaj
Chronic Disease Cost not Transferable: Colombian Reality
Objective: The aim is to reflect on the social and economic costs of chronic non-communicable disease (NCD) in Colombia to display a charging indicator of these pathologies.
Karina Gallardo Solarte +2 more
doaj +1 more source
Evaluating the effect of γ‐oryzanol on MASLD pathology using a medaka fish model
This study explores a liver disease called MASLD, which is increasing worldwide and can lead to serious damage. Researchers used medaka fish instead of rodents to test a food compound, γ‐oryzanol. Fish fed this compound had less liver fat and healthier gut bacteria.
Yukako Ito +7 more
wiley +1 more source

